THERAPEUTIC CLASS

A Review of Persistent Post‑COVID Syndrome (PPCS)

---

Persistent post-COVID syndrome, also referred to as long COVID, is a pathologic entity, which involves persistent physical,
medical, and cognitive sequelae following COVID-19, including persistent immunosuppression as well as pulmonary, cardiac,
and vascular fibrosis. Pathologic fibrosis of organs and vasculature leads to increased mortality and severely worsened quality
of life. Inhibiting transforming growth factor beta (TGF-β), an immuno- and a fibrosis modulator, may attenuate these post-
COVID sequelae. Current preclinical and clinical efforts are centered on the mechanisms and manifestations of COVID-19
and its presymptomatic and prodromal periods; by comparison, the postdrome, which occurs in the aftermath of COVID-19,
which we refer to as persistent post-COVID-syndrome, has received little attention

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Other Therapeutic Products

Specific Detail Info

https://doi.org/10.1007/s12016-021-08848-3

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment